Attachments
  
  
Details
  
  
  
  
  

Bulatova, N. R., Kasabri, V. N., Albsoul, A. M., Halaseh, L., & Suyagh, M. (2023). The Clinical Utility of salivary oxytocin as a putatively surrogate early Risk Identification biomarker of nascent Metabolic Syndrome with and without prediabetes.

https://doi.org/10.21203/rs.3.rs-2587738/v1




Biopharmaceutics and Clinical PharmacyBiopharmaceutics and Clinical Pharmacy4/24/2023Biopharmaceutics and Clinical Pharmacy
  

Alhawamdeh, E., Bulatova, N. R., Al Motassem, F. Y., AlAbbadi, M. A., & Omer, E. A. (2023). A Cross-sectional Study of the Catalase Genetic Polymorphism (-262 cytosine/thymine) and Blood Catalase Activity among Jordanian Vitiligo Patients. Jordan Journal of Pharmaceutical Sciences, 330-344.

DOI: 

https://doi.org/10.35516/jjps.v16i2.438


Biopharmaceutics and Clinical PharmacyBiopharmaceutics and Clinical Pharmacy9/1/2023Biopharmaceutics and Clinical Pharmacy
  

Al-Btoush, H. A., Aleidi, S. M., Al-Odinat, H. A., & Qaisi, N. T. (2023). Assessment of knowledge, behaviour and awareness towards antibiotic use and resistance: a cross sectional study from south Jordanian society. Journal of Pharmaceutical Health Services Research, rmad024.

https://doi.org/10.1093/jphsr/rmad024

Biopharmaceutics and Clinical PharmacyBiopharmaceutics and Clinical Pharmacy9/5/2023Biopharmaceutics and Clinical Pharmacy
  

Altawalbeh, S. M., Wali, L. M., Alshogran, O. Y., Hammad, E. A., & Tahaineh, L. (2023). Incidence, predictors, clinical outcomes, and economic burden of recurrent acute kidney injury: a retrospective cohort study. Current Medical Research and Opinion39(3), 399-407.


Biopharmaceutics and Clinical PharmacyBiopharmaceutics and Clinical Pharmacy9/6/2023Biopharmaceutics and Clinical Pharmacy
  

Bustanji, Y., Shihab, K. H. A., El-Huneidi, W., Semreen, M. H., Abu-Gharbieh, E., Alzoubi, K. H., ... & Faris, M. E. (2023). Analysis and mapping of global scientific research on human monkeypox over the past 20 years. Veterinary World16(4), 693.

doi: 10.14202/vetworld.2023.693-703

Biopharmaceutics and Clinical PharmacyBiopharmaceutics and Clinical Pharmacy9/11/2023Biopharmaceutics and Clinical Pharmacy
  

Qaisi, A. M., Al Tawaha, A. R., Imran, & Al-Rifaee, M. D. (2023). Effects of Chitosan and Biochar-mended soil on growth, yield and yield components and mineral composition of fenugreek. Gesunde Pflanzen75(3), 625-636.

Pharmaceutical SciencesPharmaceutical Sciences9/11/2023Pharmaceutical Sciences
  

Jaber, A. M., Al-Mahadeen, M. M., Al-Qawasmeh, R. A., & Taha, M. O. (2023). Synthesis, anticancer evaluation and docking studies of novel adamantanyl-1, 3, 4-oxadiazol hybrid compounds as Aurora-A kinase inhibitors. Medicinal Chemistry Research, 1-11.

Pharmaceutical SciencesPharmaceutical Sciences9/11/2023Pharmaceutical Sciences
  

Mansour, R. S., Al Khawaja, A. Y., Hamdan, I. I., & Khalil, E. A. (2023). IR microspectroscopic investigation of the interaction of some losartan salts with human stratum corneum protein and its effect on losartan transdermal permeation. Plos one18(6), e0287267.

https://doi.org/10.1371/journal.pone.0287267


Pharmaceutical SciencesPharmaceutical Sciences9/13/2023Pharmaceutical Sciences
  

Al-Nadaf, A. H., Awadallah, A., & Bardaweel, S. (2023). Raloxifene's in vitro anticancer effects against MCF-7 cells were facilitated by cholesterol-PEG functionalized mesoporous silica nanoparticles. Journal of Drug Delivery Science and Technology86, 104736.

https://doi.org/10.1016/j.jddst.2023.104736

Pharmaceutical SciencesPharmaceutical Sciences9/12/2023Pharmaceutical Sciences
  

Dahabiyeh, L. A., Nimer, R. M., Rashed, M., Wells, J. D., & Fiehn, O. (2023). Serum-Based Lipid Panels for Diagnosis of Idiopathic Parkinson’s Disease. Metabolites13(9), 990.

https://doi.org/10.3390/metabo13090990

Pharmaceutical SciencesPharmaceutical Sciences9/13/2023Pharmaceutical Sciences
  

AlMuhaissen, S. A., Elayeh, E., Sharaydih, R., Abdullah, T. M., AlShalalfeh, A., & AlKhatib, H. S. (2023). Doctor of pharmacy as a career option: a cross-sectional study exploring PharmD students and practitioners expectations in Jordan. Human Resources for Health21(1), 1-12.

Pharmaceutics and Pharmaceutical TechnologyPharmaceutics and Pharmaceutical Technology9/11/2023Pharmaceutics and Pharmaceutical Technology
  

Darwish, R. M., & Salama, A. H. (2023). A pilot study on ultrashort peptide with fluconazole: A promising novel anticandidal combination. Veterinary World16(6), 1284.

doi: 10.14202/vetworld.2023.1284-1288

Pharmaceutics and Pharmaceutical TechnologyPharmaceutics and Pharmaceutical Technology9/10/2023Pharmaceutics and Pharmaceutical Technology
  

Darwish, R. M., AlMasri, M., Ammar, K., AlMasri, R., Al-Najar, H., & Al-Masri, M. M. (2023). Assessing pharmacists and other healthcare providers’ knowledge of hand sanitization during COVID-19 pandemic in Jordan: A comparative study. Plos one18(4), e0283328.

https://doi.org/10.1371/journal.pone.0283328


Pharmaceutics and Pharmaceutical TechnologyPharmaceutics and Pharmaceutical Technology9/5/2023Pharmaceutics and Pharmaceutical Technology
  

Abulateefeh, S. R. (2023). Long-acting injectable PLGA/PLA depots for leuprolide acetate: successful translation from bench to clinic. Drug Delivery and Translational Research13(2), 520-530.

Pharmaceutics and Pharmaceutical TechnologyPharmaceutics and Pharmaceutical Technology9/6/2023Pharmaceutics and Pharmaceutical Technology
  

Al-Rifai, N., Amro, R., Zahra, J. A., Darras, F., & Taha, M. O. (2025). Novel diazepine-carbamate derivatives as dual-acting butyrylcholinesterase inhibitors and antioxidants for Alzheimer’s disease. Medicinal Chemistry Research, 1-18.

https://doi.org/10.1007/s00044-025-03484-4​


Pharmaceutical SciencesPharmaceutical Sciences10/19/2025Pharmaceutical Sciences
  

Bardaweel, S. K., Abu Sneineh, B., Hajjo, R., & Abu Khalaf, R. (2025). DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insights. PloS one20(10), e0334223.

https://doi.org/10.1371/journal.pone.0334223


Pharmaceutical SciencesPharmaceutical Sciences10/10/2025Pharmaceutical Sciences
  

Al-Masri, M., Darwish, R., Safi, Y., Mustafa, A., Alzyoud, D., Almasri, M., ... & Khader, M. (2025). Herbal and alternative medicine use: a cross sectional study to evaluate the prevalence and predictors of use in cancer patients. Frontiers in Pharmacology16, 1535795.

https://doi.org/10.3389/fphar.2025.1535795

Pharmaceutics and Pharmaceutical TechnologyPharmaceutics and Pharmaceutical Technology5/15/2025Pharmaceutics and Pharmaceutical Technology
  

Hamdan, I. I., El-Sabawi, D., Ramazanov, R. R., Lantushenko, A. O., Evstigneev, M. P., Altaher, A., ... & Bani-Jaber, A. (2025). Valsartan–Choline: Preparation, Characterization, and transdermal permeation. Journal of Molecular Liquids419, 126827.

https://doi.org/10.1016/j.molliq.2024.126827

Pharmaceutics and Pharmaceutical TechnologyPharmaceutics and Pharmaceutical Technology2/1/2025Pharmaceutics and Pharmaceutical Technology
  

Abdaljaleel, S., Hijazeen, R., Jalil, M. A., & Awwad, O. (2025). Antimicrobial prophylaxis for endourological procedures in Jordanian hospitals: a multi-centre qualitative study. BMJ open15(5), e095668.

https://doi.org/10.1136/bmjopen-2024-095668

Biopharmaceutics and Clinical PharmacyBiopharmaceutics and Clinical Pharmacy5/1/2025Biopharmaceutics and Clinical Pharmacy
  

Alshelleh, S., Suyagh, M., Alhawari, H., Bulatova, N., Kasabri, V., Wahbeh, A., ... & Mustafa, H. (2025). Combinatorial multiplicity of cardiometabolic and inflammatory markers in gum arabica modality of CKD CAM: Part 2. Pharmacy Practice23(3), 1-17.

https://doi.org/10.18549/PharmPract.2025.3.3240​



Biopharmaceutics and Clinical PharmacyBiopharmaceutics and Clinical Pharmacy10/8/2025Biopharmaceutics and Clinical Pharmacy